Skip to content
July 01, 2022

Equity.Guru

Investment information for the new generation

Search Results for: mcur.c

Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a hit. This could just…
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments…
Jody speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden, to get a better idea of how the company combines psychedelic research, technology, and medicines to optimize…
Mind Cure is a life sciences company that develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics tech and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
An exciting point in the markets for Psychedelics! The technicals currently indicate money returning to the psychedelics sector. Now we just look for charts that are about to breakout,…
Today Maddy speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden. Kelsey breaks down the burgeoning therapeutic world of psychedelics and outlines Mindcure’s uniquely comprehensive approach of…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Oura Rings I have an Oura Ring, I bought it a few years back to try and better understand my sleeping patterns. After a few months of use, I…
Mind Cure Health (MCUR.C) announced they have launched the second stage of manufacturing pharmaceutical grade ibogaine to be used in clinical research. MINDCURE will be assessing the quality of…